An endothelin receptor antagonist ameliorates injuries of sinusoid lining cells in porcine liver transplantation

American Journal of Surgery

Volumn 178, Issue 1, 1999, Pages 64-68

  Fukunaga, Kiyoshi ^a   Takada, Yasutsugu ^a   Mei, Gu ^a   Taniguchi, Hideki ^a   Seino, Kenichiro ^a   Yuzawa, Kenji ^a   Otsuka, Masaaki ^a   Todoroki, Takeshi ^a   Goto, Katsutoshi ^a   Fukao, Katashi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; INDOCYANINE GREEN; TAK 044; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GRAFT SURVIVAL; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER PROTECTION; LIVER SINUSOID; LIVER TRANSPLANTATION; NONHUMAN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; SWINE;

ANIMALS; GRAFT SURVIVAL; HEART ARREST; LIVER TRANSPLANTATION; PEPTIDES, CYCLIC; RECEPTORS, ENDOTHELIN; REPERFUSION INJURY; SWINE; TISSUE DONORS;

EID: 0032856263     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00107-5     Document Type: Article

References (25)

1. Harper A.M., Baker A.S. The UNOS OPTN waiting list 1988-1995 . Clin Transpl. 1995;69-84.
2. Cassavilla A., Ramirez C., Shapiro R., et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation. 59:1995;197-203.
3. D'Alessandro A.M., Hoffmann R.M., Knechtle S.J., et al. Successful extrarenal transplantation from non-heart-beating donors. Transplantation. 59:1995;977-982.
4. Goto M., Takei Y., Kawano S., et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology. 19:1994;675-681.
5. Nakamura S., Nishiyama R., Serizawa A., et al. Hepatic release of endothelin-1 after warm ischemia. Reperfusion injury and its hemodynamic effect. Transplantation. 59:1995;679-684.
6. Kawamura E., Yamanaka N., Okamoto E., et al. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology. 21:1995;1138-1143.
7. Okumura S., Takei Y., Kawano S., et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology. 19:1994;155-161.
8. Kikuchi T., Ohtaki T., Kawata A., et al. Cyclic hexapeptide endothelin receptor antagonists highly potent for both receptor subtypes ETA and ETB. Biochem Biophys Res Commun. 200:1994;1708-1712.
9. Kitayama Y., Yamanaka N., Kawamura E., et al. Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver. Hepatology. 25:1997;938-942.
10. Plumpton C., Ferro C.J., Haynes W.G., et al. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol. 119:1996;311-314.
11. Sumimoto R., Jamieson N.V., Wake K., Kamada N. 24-Hour rat liver preservation using UW solution and some simplified variants. Transplantation. 48:1989;1-5.
12. Jamieson N.V., Sundberg R., Lindell S., et al. Preservation of the canine liver for 24-48 hours using simple cold storage with UW solution. Transplantation. 46:1988;517-522.
13. Howden B.O., Jablonski P., Thomas A.C., et al. Liver preservation with UW solution. I. Evidence that hydroxyethyl starch is not essential. Transplantation. 49:1990;869-872.
14. Xu H.S., Stevenson W.C., Pruett T.L., Jones R.S. Donor lazaroid pretreatment improves viability of livers harvested from non-heart-beating rats. Am J Surg. 165:1996;113-117.
15. Takada Y., Taniguchi H., Fukunaga K., et al. Prolonged hepatic warm ischemia in non-heart-beating donors protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation . Surgery. 123:1998;692-698.
16. Fukunaga K., Takada Y., Taniguchi H., et al. Protecting the viability of hepatic allografts procured from non-heart-beating donors by blockade of endothelin and platelet activating factor in porcine liver transplantation. Int Surg. 83:1998;226-231.
17. Fukunaga K., Takada Y., Taniguchi H., et al. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors. Transplantation. 67:1999;328-332.
18. Takada Y., Boudjema K., Jaeck D., et al. Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation. Transplantation. 59:1995;10-16.
19. Boudjema K., Lindell S.L., Southard J.H., Belzer F.O. The effect of fasting on the quality of liver preservation by simple cold storage. Transplantation. 50:1990;943-948.
20. Ikeda T., Yanaga K., Kishikawa K., et al. Ischemic injury in liver transplantation difference in injury sites between warm and cold ischemia in rats . Hepatology. 16:1992;454-461.
21. Marzi I., Zhong Z., Lemasters J.J., et al. Evidence that graft survival is not related to parenchymal cell viability in rat liver transplantation. Transplantation. 48:1989;463-468.
22. Tomita I., Sawa M., Munakata T., et al. The beneficial effect of dibutyryl cyclic adenosine monophosphate on warm ischemic injury of the rat liver induced by cardiac arrest. Transplantation. 62:1996;167-173.
23. Nakagami M., Morimoto T., Mitsuyoshi A., et al. Difference in onset of warm ischemia and reperfusion injury between parenchymal and endothelial cells of the liver. Evaluation by purine nucleoside phosphorylase and hyaluronic acid. J Surg Res. 62:1995;118-124.
24. Rosen H.R., Martin P., Goss J., et al. Significance of early aminotransferase elevation after liver transplantation. Transplantation. 65:1998;68-72.
25. Colina F., Lopez-Carreira M., Moreno E., et al. A clinopathologic review of 8 liver graft primary nonfunctions. Hepato-Gastroenterology. 42:1995;212-221.